The Clinical and Pathological Characteristics of Patients with Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits
Glomerular Diseases · 20.02.2025 · 5 (1) · 142-150
DOI: 10.1159/000544864 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glomerular Diseases, online erschienen am 20.02.2025. Verfasst von Tariku T Gudura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kidney Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Proliferative glomerulonephritis with monoclonal immunoglobin (Ig) deposits (PGNMID) is a rare form of kidney disease associated with low monoclonal protein detection rates and poor renal outcomes. The lack of effective therapy is partly due to limited data and understanding of its pathogenesis.
Methods
We conducted a retrospective analysis of 18 patients with PGNMID from the Cleveland Clinic Kidney Biopsy Epidemiology Project from January 2015 to March 2023.
Results
PGNMID was more predominant among males (67%), and whites (78%), with median age of 60 years. Over 2/3rd of patients presented with hypertension, renal insufficiency, and hematuria, while 26% of patients had nephrotic syndrome. Mean serum creatinine and proteinuria at biopsy were 3.2 mg/dL and 4.3 g/g, respectively. A detectable monoclonal (M) protein was detected in 28% of cases; however, only 3 patients had underlying hematologic disorders (multiple myeloma, CLL, and B-cell lymphoma). An endocapillary hypercellularity/membranoproliferative pattern (72%), IgG/kappa (83%), and IgG3 (56%) were predominant findings on kidney pathology. Eight patients (44%) progressed to end-stage kidney disease (ESKD), with a median onset of 7.5 months after the initial kidney biopsy. While 6 patients achieved complete remission primarily with clone-directed therapy.
Conclusion
Despite monoclonal protein deposition on kidney biopsy, 28% patients with PGNMID had a detectable monoclonal protein. Unlike other forms of paraproteinemic kidney diseases, renal outcomes for patients with PGNMID are poor, with 44% progressing to ESKD (median time 7.5 months) after kidney biopsy in our cohort. Clone-directed therapy to improve outcomes remains the mainstay of treatment, despite the absence of detectable clone in most cases. Thus, further investigation into the pathogenesis of PGNMID is warranted to guide future treatment discovery and clinical trials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Kidney Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.
- Department of Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.
- Department of Pathology, Cleveland Clinic Foundation, Cleveland, OH, USA.
- Department of Kidney Medicine, Cleveland Clinic Florida, Weston, FL, USA.
- Division of Nephrology, Hypertension and Transplantation, Department of Medicine, Weill Cornell Medical College, Houston Methodist Hospital, Houston, TX, USA.
Zitieren
APA
Gudura, T. T., Sawaf, H., Ogbenna, R., Mehdi, A., Herlitz, L., Gebreselassie, S. K., & Bobart, S. A. (2025). The Clinical and Pathological Characteristics of Patients with Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits. Glomerular Diseases, 5(1), 142-150. https://doi.org/10.1159/000544864
Vancouver
Gudura TT, Sawaf H, Ogbenna R, Mehdi A, Herlitz L, Gebreselassie SK, et al. The Clinical and Pathological Characteristics of Patients with Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits. Glomerular Diseases. 2025;5(1):142-150. doi:10.1159/000544864
BibTeX
@article{Gudura2025,
author = {Gudura, Tariku T and Sawaf, Hanny and Ogbenna, Randy and Mehdi, Ali and Herlitz, Leal and Gebreselassie, Surafel K and Bobart, Shane A},
title = {The Clinical and Pathological Characteristics of Patients with Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits},
journal = {Glomerular Diseases},
year = {2025},
volume = {5},
number = {1},
pages = {142--150},
doi = {10.1159/000544864}
}
EUVIMED